@@@@@@@@

NEWS & INFORMATION

2015.9
Foreword of Prof.Handa was published in The Journal of Tokyo Medical University, Vol.73, No.3, 2015.
2015.7.1
Prof.Handa & Dr.Ito wrote a comentary on "Myeloid disease: Another action of a thalidomide derivative" for Nature, vol523, 167-168, 2015.7.9.
2015.3.24
Dr.Arnold J.Berk, Professor in Microbiology, Immunology & Molecular Genetics of UCLA, has come to our lab.
2015.5.11
Mr.Robert.J.Hugin,Chairman and CEO of Celgene Corporation, has come to our lab.
2015.2.27
Dr.Andrew Fire, Novel Prize winner in Phisiology or Medicine and Professor of Stanford University School of Medicine, has come to our lab.
2014.11
Prof. Handa's study was introduced to a thalidomide article of the ASBMBTODAY top page. The drug of good and eviliThalidomidefs unusual mechanism of action is starting to give researchers hints as to why it can save or wreck livesj
2014.04
A new paper entitled "Magnetically Promoted Rapid Immunoreactions Using Functionalized Fluorescent Magnetic Beads: A Proof of Principle" has been published in Clinical Chemistry.Slids.
2013/12/01
We start new lab in Tokyo Medical University.


We are studying on biochemistry and biotechnology from basic science to applicable technology in a broad field of medicine,pharmacy,biology and ecology.

LINK


Contact Us
If you want to send a direct mail or send some freights to us, please use below "Mail Box" address.
Mail Box
Department of Nanoparticle Translational Research,
Tokyo Medical University,
6-1-1 Shinjuku,
Shinjuku-ku,
Tokyo,160-8402
Japan
TEL:+81-3-5323-3250
FAX:+81-3-5323-3251

Professor's Office
Shinjuku-Kokusai Building 4F,
6-2-2 Nishishinjuku,
Shinjuku-ku,
Tokyo,
Japan
TEL:+81-3-5323-3250
FAX:+81-3-5323-3251

Laboratory
Shin-kyoikukenkyu Building 14F,
6-7-1 Nishishinjuku,
Shinjuku-ku,
Tokyo,
Japan
TEL:+81-3-3342-6111
FAX:+81-3-5323-3251